We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+15.22%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.21B
AUM Growth
+$148M
Cap. Flow
+$27M
Cap. Flow %
2.23%
Top 10 Hldgs %
38.39%
Holding
516
New
39
Increased
143
Reduced
266
Closed
39

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$6.89M
2
BABA icon
Alibaba
BABA
+$4.05M
3
SLV icon
iShares Silver Trust
SLV
+$4M
4
FUTU icon
Futu Holdings
FUTU
+$3.28M
5
AVGO icon
Broadcom
AVGO
+$3.25M

Top Sells

Rank Stock Value
1
SAP icon
SAP
SAP
+$2.28M
2
TPR icon
Tapestry
TPR
+$2.13M
3
ABT icon
Abbott
ABT
+$2.05M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.05M
5
TMUS icon
T-Mobile US
TMUS
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 39.61%
2 Healthcare 20.82%
3 Communication Services 12.95%
4 Consumer Discretionary 11.61%
5 Consumer Staples 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GERN icon
351
Geron
GERN
$1.01B
$153K 0.01%
111,835
-16,087
-13% -$21.4K
ABUS icon
352
Arbutus Biopharma
ABUS
$907M
$153K 0.01%
33,602
-4,865
-13% -$17.9K
CRMD icon
353
CorMedix
CRMD
$557M
$152K 0.01%
13,085
-537
-4% -$6.49K
SION
354
Sionna Therapeutics
SION
$283M
$147K 0.01%
+5,000
New +$109K
XNCR icon
355
Xencor
XNCR
$1.72B
$147K 0.01%
12,502
-1,792
-13% -$15.6K
PHAT icon
356
Phathom Pharmaceuticals
PHAT
$742M
$146K 0.01%
12,435
-1,587
-11% -$16.4K
PAHC icon
357
Phibro Animal Health
PAHC
$1.37B
$144K 0.01%
3,570
-521
-13% -$17.2K
ARCT icon
358
Arcturus Therapeutics
ARCT
$216M
$143K 0.01%
7,760
+2,313
+42% +$37.2K
VIR icon
359
Vir Biotechnology
VIR
$1.52B
$139K 0.01%
24,350
-3,415
-12% -$17.5K
IOVA icon
360
Iovance Biotherapeutics
IOVA
$3.05B
$138K 0.01%
63,428
-3,641
-5% -$8.6K
KURA icon
361
Kura Oncology
KURA
$882M
$135K 0.01%
15,214
-2,174
-13% -$15.5K
FTRE icon
362
Fortrea Holdings
FTRE
$1.74B
$134K 0.01%
15,916
-2,261
-12% -$17.3K
AVXL icon
363
Anavex Life Sciences
AVXL
$316M
$134K 0.01%
15,056
-2,091
-12% -$21.2K
SIVR icon
364
abrdn Physical Silver Shares ETF
SIVR
$4.53B
$133K 0.01%
3,000
– –
MESO
365
Mesoblast
MESO
$2.18B
$133K 0.01%
8,276
-848
-9% -$12.4K
AVBP icon
366
ArriVent BioPharma
AVBP
$1.47B
$131K 0.01%
7,111
+240
+3% +$4.71K
TYRA icon
367
Tyra Biosciences
TYRA
$1.51B
$131K 0.01%
9,342
-1,339
-13% -$15.3K
TBPH icon
368
Theravance Biopharma
TBPH
$878M
$129K 0.01%
8,828
-1,215
-12% -$15.4K
DAWN
369
DELISTED
Day One Biopharmaceuticals
DAWN
$127K 0.01%
17,955
-2,403
-12% -$16.5K
ORKA
370
Oruka Therapeutics
ORKA
$7.11B
$126K 0.01%
6,565
-955
-13% -$14.2K
NRIX icon
371
Nurix Therapeutics
NRIX
$2.76B
$124K 0.01%
13,400
-1,912
-12% -$19.9K
AQST icon
372
Aquestive Therapeutics
AQST
$531M
$119K 0.01%
21,205
+1,255
+6% +$5.43K
OLMA icon
373
Olema Pharmaceuticals
OLMA
$913M
$118K 0.01%
12,031
-1,711
-12% -$10.3K
MGTX icon
374
MeiraGTx Holdings
MGTX
$1.2B
$116K 0.01%
14,101
-2,040
-13% -$16.1K
CSTL icon
375
Castle Biosciences
CSTL
$960M
$116K 0.01%
5,085
-714
-12% -$14.5K
13 14
15
16 17

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q3 2025 Portfolio in Review

As of Q3 2025, China Universal Asset Management Company held 516 positions worth $1.21B, up 14% from $1.06B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

China Universal Asset Management Company's Q3 2025 filing shows 39 new, 143 increased, 266 reduced and 39 closed positions. Its largest new stake was Alibaba: 30,923 shares worth $5.53M. The largest sale was SAP, an estimated $2.28M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Communication Services.

  • China Universal Asset Management Company's largest Q3 2025 buy was Alibaba: 30,923 shares worth $5.53M.
  • China Universal Asset Management Company added most to NVIDIA in Q3 2025, an estimated $6.89M increase.
  • China Universal Asset Management Company's biggest Q3 2025 reduction was SAP, cutting an estimated $2.28M.
  • China Universal Asset Management Company fully exited Tapestry in Q3 2025, selling an estimated $2.13M.
  • China Universal Asset Management Company's ten largest holdings make up 38% of its $1.21B portfolio in Q3 2025.
  • China Universal Asset Management Company opened 39 new positions and closed 39 in Q3 2025.
  • China Universal Asset Management Company's portfolio value rose 14% quarter-over-quarter to $1.21B.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.